A team of researchers from the University of Wisconsin–Madison developed a way to grow organized clusters of cells, called organoids, that resemble the retina, the light-sensitive tissue at the back of the eye.
Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for trials in humans with degenerative eye disorders.
According to a news release, more than a decade ago, researchers from the University of Wisconsin–Madison developed a way to grow organized clusters of cells, called organoids, that resemble the retina, the light-sensitive tissue at the back of the eye. They coaxed human skin cells reprogrammed to act as stem cells to develop into layers of several types of retinal cells that sense light and ultimately transmit what we see to the brain.
“We wanted to use the cells from those organoids as replacement parts for the same types of cells that have been lost in the course of retinal diseases,” said David Gamm, the UW–Madison ophthalmology professor and director of the McPherson Eye Research Institute whose lab developed the organoids. “But after being grown in a laboratory dish for months as compact clusters, the question remained — will the cells behave appropriately after we tease them apart? Because that is key to introducing them into a patient’s eye.”
According to the news release, during 2022, Gamm and UW–Madison collaborators published studies showing that dish-grown retinal cells called photoreceptors respond like those in a healthy retina to different wavelengths and intensities of light, and that once they are separated from adjacent cells in their organoid, they can reach out toward new neighbors with characteristic biological cords called axons.
“The last piece of the puzzle was to see if these cords had the ability to plug into, or shake hands with, other retinal cell types in order to communicate,” added Gamm, whose new results on successful connections between the cells will be published in the Proceedings of the National Academy of Sciences.
Cells in the retina and brain communicate across synapses, tiny gaps at the tips of their cords. To confirm that their lab-grown retinal cells have the capacity to replace diseased cells and carry sensory information like healthy ones, the researchers needed to show that they could make synapses.
Xinyu Zhao, PhD, UW–Madison professor of neuroscience and co-author of the new study, worked with the Gamm lab’s cells to help study their ability to form synaptic connections. They did this using a modified rabies virus to identify pairs of cells that could form the means to communicate with one another.
The research team, including graduate students and co-first-authors Allison Ludwig and Steven Mayerl, broke apart the retinal organoids into individual cells, gave them a week to extend their axons and make new connections, exposed them to the virus, and then took a peek. What they saw were many retinal cells marked by a fluorescent color indicating a rabies infection had infected one across a synapse successfully formed between neighbors.
“We’ve been quilting this story together in the lab, one piece at a time, to build confidence that we’re headed in the right direction,” said Gamm, who patented the organoids and co-founded Madison-based Opsis Therapeutics, which is adapting the technology to treat human eye disorders based on the UW–Madison discoveries. “It’s all leading, ultimately, to human clinical trials, which are the clear next step.”
After they confirmed the presence of synaptic connections, the researchers analyzed the cells involved and found that the most common retinal cell types forming synapses were photoreceptors – rods and cones – which are lost in diseases like retinitis pigmentosa and age-related macular degeneration, as well as in certain eye injuries. The next most common cell type, retinal ganglion cells, are degenerate in optic nerve disorders like glaucoma.
“That was an important revelation for us,” Gamm concluded. “It really shows the potentially broad impact these retinal organoids could have.”
This research was supported by federal grants from the National Institutes of Health (U01EY027266, U24EY029890, MH116582, U54HD090256, P50HD105353 and F30EY031230), the Department of Defense (W81XWH-20-1-0655), the Sandra Lemke Trout Chair in Eye Research, and the RRF Emmett A. Humble Distinguished Directorship of the McPherson ERI.